Working with alopecia patients’ insurers when using novel therapies

Описание к видео Working with alopecia patients’ insurers when using novel therapies

Read the article here: http://bit.ly/2mlZFXs

ORLANDO – Janus kinase inhibitors are “currently the most promising treatments” for alopecia areata, but they are expensive, are not approved for this indication, and so getting insurance coverage for these treatments can be difficult, Carolyn Goh, MD, said at the annual meeting of the American Academy of Dermatology.

Комментарии

Информация по комментариям в разработке

Похожие видео